China Dasheng Biotechnology Company
Cycclone Inc., together with its subsidiaries, engages in the production, marketing, and distribution of bacteria based products used as additives for livestock feed and crop cultivation in the People's Republic of China. It provides artificial microorganisms (AM) and high-efficiency microorganism (HM) based biological bacterium blends; and biological preservatives. The company offers AM/HM bacte… Read more
China Dasheng Biotechnology Company (CDBT) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2024: 0.077x
Based on the latest financial reports, China Dasheng Biotechnology Company (CDBT) has a cash flow conversion efficiency ratio of 0.077x as of December 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-58.49K) by net assets ($-755.75K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
China Dasheng Biotechnology Company - Cash Flow Conversion Efficiency Trend (2006–2023)
This chart illustrates how China Dasheng Biotechnology Company's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
China Dasheng Biotechnology Company Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of China Dasheng Biotechnology Company ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
AFRICA EATS LTD (USD)
SEM:EATS
|
N/A |
|
TANFIELD GRP
BE:XS3A
|
N/A |
|
Gateway Bank F.S.B.
PINK:GWBK
|
N/A |
|
TALISMAN MINING (RJA.SG)
STU:RJA
|
N/A |
|
Veltex Corporation
OTCQB:VLXC
|
0.045x |
|
Egyptian Arabian(Themar)Comp. For Securities&Bonds Brok. EAC
EGX:EASB
|
N/A |
|
Xebra Brands Ltd
OTCQB:XBRAF
|
0.127x |
|
PP LONDON SUMATRA (PS9A.SG)
STU:PS9A
|
N/A |
Annual Cash Flow Conversion Efficiency for China Dasheng Biotechnology Company (2006–2023)
The table below shows the annual cash flow conversion efficiency of China Dasheng Biotechnology Company from 2006 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-06-30 | $-1.21 Million | $-233.55K | 0.192x | -18.96% |
| 2008-06-30 | $17.26 Million | $4.10 Million | 0.237x | -0.75% |
| 2007-10-31 | $-67.93K | $-16.25K | 0.239x | +537.93% |
| 2007-06-30 | $10.48 Million | $392.86K | 0.038x | +100.23% |
| 2006-06-30 | $-381.00 | $6.08K | -15.961x | -- |